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Abstract
© 2016, European Biophysical Societies' Association.Protegrin pore formation is believed to
occur  in  a  stepwise  fashion  that  begins  with  a  nonspecific  peptide  interaction  with  the
negatively charged bacterial  cell  walls  via hydrophobic and positively charged amphipathic
surfaces. There are five known nature protegrins (PG1-PG5), and early studies of PG-1 (PDB
ID:1PG1) shown that it could form antiparallel dimer in membrane mimicking environment which
could be a first step for further oligomeric membrane pore formation. Later, we solved PG-2
(PDB ID:2MUH) and PG-3 (PDB ID:2MZ6) structures in the same environment and for PG-3
observed a strong dαα NOE effects  between residues R18 and F12,  V14,  and V16.  These
“inconsistent”  with  monomer  structure  NOEs  appears  due  to  formation  of  an  additional
antiparallel β-sheet between two monomers. It was also suggested that there is a possible
association of protegrins dimers to form octameric or decameric β-barrels in an oligomer state.
In order to investigate a more detailed oligomerization process of protegrins, in the present
article we report the monomer (PDB ID: 2NC7) and octamer pore structures of the protegrin-5
(PG-5) in the presence of DPC micelles studied by solution NMR spectroscopy. In contrast to PG-
1, PG-2, and PG-3 studies, for PG-5 we observed not only dimer NOEs but also several additional
NOEs between side chains, which allows us to calculate an octamer pore structure of PG-5 that
was in good agreement with previous AFM and PMF data.
http://dx.doi.org/10.1007/s00249-016-1167-5
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